Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
135 studies found for:    "Choreatic Disorders" OR "McLeod neuroacanthocytosis syndrome" OR "Neuroacanthocytosis" OR "Chorea Acanthocytosis Syndromes"
Show Display Options
Rank Status Study
21 Completed Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Other: Placebo
22 Completed Working Memory Training in Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Cogmed QM
23 Terminated Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 "After Multiple Oral Doses" in Healthy Volunteers
Condition: Huntington Disease
Interventions: Drug: PBF-999 / 160 mg;   Drug: PBF-999 / 320 mg;   Drug: Placebo
24 Not yet recruiting FuRST 2.0 Cognitive Pre-Testing
Condition: Huntington's Disease
Intervention: Behavioral: FuRST 2.0
25 Completed Caregiver Burden in Huntington's Disease
Condition: Caregiver of Huntington's Disease Patient
Intervention: Other: ZARIT Burden Interview
26 Not yet recruiting HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Condition: Huntington's Disease
27 Recruiting Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)
Conditions: Frontotemporal Dementia;   Huntington Disease;   Alzheimer Disease;   Semantic Dementia;   Dementia, Vascular
Intervention: Behavioral: prevalence of behavioural dysexecutive syndrome
Conditions: Parkinson Disease;   Huntington Disease
Intervention: Behavioral: SRT
29 Recruiting Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
Conditions: Alzheimer's Disease;   Amyotrophic Lateral Sclerosis;   Brain Injury;   Huntington's Disease;   Multiple Sclerosis;   Parkinson's Disease;   Stroke;   Spinal Cord Injury
Intervention: Other: Laughter Therapy
30 Not yet recruiting Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Cellavita HD lower dose;   Other: Cellavita HD intermediate dose;   Other: Cellavita HD Higher dose
31 Recruiting Dynamic Neuroimaging Biomarkers in Huntington's Disease
Condition: Brain Neuroimaging Biomarkers in Huntington Disease
32 Recruiting Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
Condition: Huntington Disease
Intervention: Device: Eye-tracking
33 Not yet recruiting Functional Imaging of Social Cognition in Premanifest Huntington's Disease
Condition: Huntington's Disease
Intervention: Other: functional Imaging
34 Recruiting Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging
Condition: Huntington's Disease
Interventions: Behavioral: neuropsychological test;   Radiation: MRI
35 Recruiting Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)
Condition: Huntington Disease
Intervention: Device: ACTIVA® PC neurostimulator (Model 37601)
36 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: IONIS HTTRx;   Drug: Placebo
37 Recruiting A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
Condition: Huntington's Disease
Intervention: Drug: Tetrabenazine
38 Recruiting Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
Conditions: Irritable Mood;   Huntington's Disease
Interventions: Drug: SRX246;   Drug: Placebo
39 Enrolling by invitation A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Pridopidine
40 Active, not recruiting VX15/2503 Treatment for Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: VX15/2503;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years